癲癇用設備的全球市場:2022-2030年
市場調查報告書
商品編碼
1142632

癲癇用設備的全球市場:2022-2030年

Global Epilepsy Devices Market Forecast 2022-2030

出版日期: | 出版商: Inkwood Research | 英文 230 Pages | 商品交期: 2-3個工作天內

價格

全球癲癇用設備的市場規模,預計從2022年到2030年的預測期間內記錄7.83%的年複合成長率。

癲癇患者數增加,起因於神經囊胞性疾病和瘧疾等地方疾病的風險上升。還有醫療基礎設施的變動,生產相關傷害,交通事故傷害增加,容易利用的照護和預防醫療計劃的可用性等要素也促進該市場的成長。再加上老年人因為容易癲癇發病,平均年齡的上升也預計刺激市場需求。

本報告提供全球癲癇用設備的市場調查,市場概要,市場成長的各種影響因素分析,法律制度,市場規模的變化、預測,各種區分、各地區/主要國家的明細,競爭情形,主要企業簡介等彙整資訊。

目錄

第1章 調查範圍、調查手法

第2章 摘要整理

第3章 市場動態

  • 主要的促進因素
  • 主要的阻礙因素

第4章 主要分析

  • COVID-19影響
  • 趨勢
  • 波特的五力分析
  • 機會矩陣
  • 業者情勢
  • 價值鏈分析
  • 主要的購買標準
  • 法律規範

第5章 各產品類型市場

  • 傳統設備
  • 穿戴式設備
    • 手錶
    • 腕帶
    • 相機設備
    • 床墊設備
    • 窒息防止枕頭
    • 其他
  • 置入式設備

第6章 各技術市場

  • 迷走神經刺激
  • 腦深部刺激
    • 異動症
    • 癲癇
  • 加速計
  • 響應能力神經刺激

第7章 檢測&預測設備類型市場

  • 腦波
  • 顱內腦波
  • 表面肌電圖
  • 心電圖
  • 影音檢測系統
  • 皮膚電力活動
  • 置入式諮詢系統
  • 其他

第8章 各終端用戶市場

  • 醫院、診所
  • 神經中心
  • 居家護理設定
  • 其他

第9章 地區分析

  • 北美
    • 市場規模、估計
    • 主要的成長要素
    • 主要課題
    • 主要企業
    • 各國分析
  • 歐洲
    • 市場規模、估計
    • 主要的成長要素
    • 主要課題
    • 主要企業
    • 各國分析
  • 亞太地區
    • 市場規模、預測
    • 主要的成長要素
    • 主要課題
    • 主要企業
    • 各國分析
  • 其他地區
    • 市場規模、預測
    • 主要的成長要素
    • 主要課題
    • 主要企業
    • 地區分析

第10章 競爭情形

  • 主要的策略性展開
  • 企業簡介
    • BOSTON SCIENTIFIC CORPORATION
    • CADWELL INDUSTRIES INC
    • COMPUMEDICS LIMITED
    • DRAGERWERK AG & CO KGAA
    • EMPATICA INC
    • KONINKLIJKE PHILIPS NV
    • LIVANOVA PLC
    • MEDTRONIC PLC
    • NATUS MEDICAL INCORPORATED
    • NEUROPACE INC
    • NEUROSOFT
    • NIHON KOHDEN CORPORATION
    • SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO LTD
Product Code: 48692

KEY FINDINGS

The global epilepsy devices market is projected to record a 7.83% CAGR during the assessment period 2022-2030. Soaring number of epilepsy cases, onset of epilepsy in elderly people, and surge in post-traumatic epilepsy (PTE) due to rising incidences of brain injuries.

MARKET INSIGHTS

The growing number of epilepsy cases is owing to an increased risk of endemic conditions such as neurocysticercosis or malaria. Also, the major drivers for the studied market are variations in medical infrastructure, birth-related injuries, the increasing number of road traffic injuries, and the availability of accessible care and preventive health programs. Lack of sleep, illness, medication errors, and drugs such as cocaine and alcohol pave the way for epileptic seizures. Also, as the geriatric population is more prone to epilepsy, the rising average age is anticipated to fuel the demand for the global epilepsy devices market.

Furthermore, recent research has produced findings for probabilistic seizure risk projections using electronic seizure diaries and long-term wearable technologies. The cognitive function, symptoms, and mood of an individual may also have predictive significance. However, seizure forecasting necessitates ongoing monitoring with a device, making user acceptance of the method even more crucial.

REGIONAL INSIGHTS

The global epilepsy devices welding market growth analysis includes the assessment of Europe, Asia-Pacific, North America, and Rest of World. North America is set to capture the highest market share during the forecast period due to the presence of the headquarters of major key companies, favorable government policies, and developed healthcare infrastructure.

COMPETITIVE INSIGHTS

The overall degree of competition in the epilepsy devices market is moderate. A moderate product differentiation among existing players propels the intensity of rivalry globally in the epilepsy devices market. Any company developing epilepsy device systems that wish to join the market must accept and follow the needed regulatory criteria. Therefore, the threat of new entrants in the market for epilepsy devices globally is low.

Some of the players operating in the market include: LivaNova PLC, Koninklijke Philips NV, Natus Medical Incorporated, Medtronic PLC, etc.

Our report offerings include:

  • Explore key findings of the overall market
  • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
  • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
  • Market Segmentation caters to a thorough assessment of key segments with their market estimations
  • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
  • Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
  • Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
  • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

TABLE OF CONTENTS

1. RESEARCH SCOPE & METHODOLOGY

  • 1.1. STUDY OBJECTIVES
  • 1.2. SCOPE OF STUDY
  • 1.3. METHODOLOGY
  • 1.4. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

  • 2.1. MARKET SIZE & ESTIMATES
  • 2.2. MARKET OVERVIEW

3. MARKET DYNAMICS

  • 3.1. KEY DRIVERS
    • 3.1.1. SOARING OCCURRENCES OF EPILEPSY GLOBALLY
    • 3.1.2. ONSET OF EPILEPSY IN ELDERLY PEOPLE
    • 3.1.3. MITIGATION OF EPILEPSY USING EARLY DIAGNOSIS
    • 3.1.4. SURGE IN POST-TRAUMATIC EPILEPSY WITH RISING BRAIN INJURY CASES
  • 3.2. KEY RESTRAINTS
    • 3.2.1. MISPERCEPTIONS AND MISINFORMATION ABOUT EPILEPSY
    • 3.2.2. SHORTAGE OF NEUROLOGY SPECIALISTS IN THE HEALTHCARE SYSTEM

4. KEY ANALYTICS

  • 4.1. IMPACT OF COVID-19 ON EPILEPSY DEVICES MARKET
  • 4.2. KEY MARKET TRENDS
  • 4.3. PORTER'S FIVE FORCES ANALYSIS
    • 4.3.1. BUYERS POWER
    • 4.3.2. SUPPLIERS POWER
    • 4.3.3. SUBSTITUTION
    • 4.3.4. NEW ENTRANTS
    • 4.3.5. INDUSTRY RIVALRY
  • 4.4. OPPORTUNITY MATRIX
  • 4.5. VENDOR LANDSCAPE
  • 4.6. VALUE CHAIN ANALYSIS
  • 4.7. KEY BUYING CRITERIA
    • 4.7.1. COMFORT & USABILITY
    • 4.7.2. PRODUCT FEATURES
    • 4.7.3. CONFIDENTIALITY
  • 4.8. REGULATORY FRAMEWORK

5. MARKET BY PRODUCT TYPE

  • 5.1. CONVENTIONAL DEVICES
  • 5.2. WEARABLE DEVICES
    • 5.2.1. WATCHES
    • 5.2.2. BRACELETS
    • 5.2.3. CAMERA DEVICES
    • 5.2.4. MATTRESS DEVICES
    • 5.2.5. ANTI-SUFFOCATION PILLOWS
    • 5.2.6. OTHER WEARABLE DEVICES
  • 5.3. IMPLANTABLE DEVICES

6. MARKET BY TECHNOLOGY

  • 6.1. VAGUS NERVE STIMULATION
  • 6.2. DEEP BRAIN STIMULATION
    • 6.2.1. MOVEMENT DISORDERS
    • 6.2.2. EPILEPSY
  • 6.3. ACCELEROMETRY
  • 6.4. RESPONSIVE NEUROSTIMULATION

7. MARKET BY DETECTION & PREDICTION DEVICES TYPE

  • 7.1. ELECTROENCEPHALOGRAM
  • 7.2. INTRACRANIAL EEG
  • 7.3. SURFACE ELECTROMYOGRAPHY
  • 7.4. ELECTROCARDIOGRAPHY
  • 7.5. VIDEO DETECTION SYSTEMS
  • 7.6. ELECTRODERMAL ACTIVITY
  • 7.7. IMPLANTED ADVISORY SYSTEMS
  • 7.8. OTHER DETECTION & PREDICTION DEVICE TYPES

8. MARKET BY END-USER

  • 8.1. HOSPITALS & CLINICS
  • 8.2. NEUROLOGY CENTERS
  • 8.3. HOME CARE SETTINGS
  • 8.4. OTHER END-USERS

9. GEOGRAPHICAL ANALYSIS

  • 9.1. NORTH AMERICA
    • 9.1.1. MARKET SIZE & ESTIMATES
    • 9.1.2. KEY GROWTH ENABLERS
    • 9.1.3. KEY CHALLENGES
    • 9.1.4. KEY PLAYERS
    • 9.1.5. COUNTRY ANALYSIS
      • 9.1.5.1. UNITED STATES
      • 9.1.5.2. CANADA
  • 9.2. EUROPE
    • 9.2.1. MARKET SIZE & ESTIMATES
    • 9.2.2. KEY GROWTH ENABLERS
    • 9.2.3. KEY CHALLENGES
    • 9.2.4. KEY PLAYERS
    • 9.2.5. COUNTRY ANALYSIS
      • 9.2.5.1. UNITED KINGDOM
      • 9.2.5.2. GERMANY
      • 9.2.5.3. FRANCE
      • 9.2.5.4. ITALY
      • 9.2.5.5. SPAIN
      • 9.2.5.6. NORDIC COUNTRIES
      • 9.2.5.7. REST OF EUROPE
  • 9.3. ASIA-PACIFIC
    • 9.3.1. MARKET ESTIMATES & SIZES
    • 9.3.2. KEY GROWTH ENABLERS
    • 9.3.3. KEY CHALLENGES
    • 9.3.4. KEY PLAYERS
    • 9.3.5. COUNTRY ANALYSIS
      • 9.3.5.1. CHINA
      • 9.3.5.2. JAPAN
      • 9.3.5.3. INDIA
      • 9.3.5.4. SOUTH KOREA
      • 9.3.5.5. INDONESIA
      • 9.3.5.6. SINGAPORE
      • 9.3.5.7. TAIWAN
      • 9.3.5.8. AUSTRALIA & NEW ZEALAND
      • 9.3.5.9. REST OF ASIA-PACIFIC
  • 9.4. REST OF WORLD
    • 9.4.1. MARKET ESTIMATES & SIZES
    • 9.4.2. KEY GROWTH ENABLERS
    • 9.4.3. KEY CHALLENGES
    • 9.4.4. KEY PLAYERS
    • 9.4.5. REGIONAL ANALYSIS
      • 9.4.5.1. LATIN AMERICA
      • 9.4.5.2. MIDDLE EAST & AFRICA

10. COMPETITIVE LANDSCAPE

  • 10.1. KEY STRATEGIC DEVELOPMENTS
    • 10.1.1. ACQUISITIONS
    • 10.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
    • 10.1.3. PARTNERSHIPS
  • 10.2. COMPANY PROFILES
    • 10.2.1. BOSTON SCIENTIFIC CORPORATION
    • 10.2.2. CADWELL INDUSTRIES INC
    • 10.2.3. COMPUMEDICS LIMITED
    • 10.2.4. DRAGERWERK AG & CO KGAA
    • 10.2.5. EMPATICA INC
    • 10.2.6. KONINKLIJKE PHILIPS NV
    • 10.2.7. LIVANOVA PLC
    • 10.2.8. MEDTRONIC PLC
    • 10.2.9. NATUS MEDICAL INCORPORATED
    • 10.2.10. NEUROPACE INC
    • 10.2.11. NEUROSOFT
    • 10.2.12. NIHON KOHDEN CORPORATION
    • 10.2.13. SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO LTD

LIST OF TABLES

  • TABLE 1: MARKET SNAPSHOT - EPILEPSY DEVICES
  • TABLE 2: EXAMPLES OF ANTIEPILEPTIC DRUGS FOR THE ELDERLY AND THEIR ADVANTAGES
  • TABLE 3: EXAMPLES OF MOBILE EEG DEVICES
  • TABLE 4: REGULATORY FRAMEWORK
  • TABLE 5: GLOBAL EPILEPSY DEVICES MARKET, BY PRODUCT TYPE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 6: GLOBAL EPILEPSY DEVICES MARKET, BY PRODUCT TYPE, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 7: GLOBAL CONVENTIONAL DEVICES MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 8: GLOBAL CONVENTIONAL DEVICES MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 9: GLOBAL WEARABLE DEVICES MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 10: GLOBAL WEARABLE DEVICES MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 11: GLOBAL EPILEPSY DEVICES MARKET, BY WEARABLE DEVICES, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 12: GLOBAL EPILEPSY DEVICES MARKET, BY WEARABLE DEVICES, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 13: GLOBAL WATCHES MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 14: GLOBAL WATCHES MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 15: GLOBAL BRACELETS MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 16: GLOBAL BRACELETS MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 17: GLOBAL CAMERA DEVICES MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 18: GLOBAL CAMERA DEVICES MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 19: GLOBAL MATTRESS DEVICES MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 20: GLOBAL MATTRESS DEVICES MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 21: GLOBAL ANTI-SUFFOCATION PILLOWS MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 22: GLOBAL ANTI-SUFFOCATION PILLOWS MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 23: GLOBAL OTHER WEARABLE DEVICES MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 24: GLOBAL OTHER WEARABLE DEVICES MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 25: GLOBAL IMPLANTABLE DEVICES MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 26: GLOBAL IMPLANTABLE DEVICES MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 27: GLOBAL EPILEPSY DEVICES MARKET, BY TECHNOLOGY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 28: GLOBAL EPILEPSY DEVICES MARKET, BY TECHNOLOGY, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 29: GLOBAL VAGUS NERVE STIMULATION MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 30: GLOBAL VAGUS NERVE STIMULATION MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 31: GLOBAL DEEP BRAIN STIMULATION MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 32: GLOBAL DEEP BRAIN STIMULATION MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 33: GLOBAL EPILEPSY DEVICES MARKET, BY DEEP BRAIN STIMULATION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 34: GLOBAL EPILEPSY DEVICES MARKET, BY DEEP BRAIN STIMULATION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 35: GLOBAL MOVEMENT DISORDERS MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 36: GLOBAL MOVEMENT DISORDERS MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 37: GLOBAL EPILEPSY MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 38: GLOBAL EPILEPSY MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 39: GLOBAL ACCELEROMETRY MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 40: GLOBAL ACCELEROMETRY MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 41: GLOBAL RESPONSIVE NEUROSTIMULATION MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 42: GLOBAL RESPONSIVE NEUROSTIMULATION MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 43: GLOBAL EPILEPSY DEVICES MARKET, BY DETECTION & PREDICTION DEVICES TYPE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 44: GLOBAL EPILEPSY DEVICES MARKET, BY DETECTION & PREDICTION DEVICES TYPE, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 45: GLOBAL ELECTROENCEPHALOGRAM MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 46: GLOBAL ELECTROENCEPHALOGRAM MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 47: GLOBAL INTRACRANIAL EEG MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 48: GLOBAL INTRACRANIAL EEG MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 49: GLOBAL SURFACE ELECTROMYOGRAPHY MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 50: GLOBAL SURFACE ELECTROMYOGRAPHY MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 51: GLOBAL ELECTROCARDIOGRAPHY MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 52: GLOBAL ELECTROCARDIOGRAPHY MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 53: GLOBAL VIDEO DETECTION SYSTEMS MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 54: GLOBAL VIDEO DETECTION SYSTEMS MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 55: GLOBAL ELECTRODERMAL ACTIVITY MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 56: GLOBAL ELECTRODERMAL ACTIVITY MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 57: GLOBAL IMPLANTED ADVISORY SYSTEMS MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 58: GLOBAL IMPLANTED ADVISORY SYSTEMS MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 59: GLOBAL OTHER DETECTION & PREDICTION DEVICE TYPES MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 60: GLOBAL OTHER DETECTION & PREDICTION DEVICE TYPES MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 61: GLOBAL EPILEPSY DEVICES MARKET, BY END-USER, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 62: GLOBAL EPILEPSY DEVICES MARKET, BY END-USER, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 63: GLOBAL HOSPITALS & CLINICS MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 64: GLOBAL HOSPITALS & CLINICS MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 65: GLOBAL NEUROLOGY CENTERS MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 66: GLOBAL NEUROLOGY CENTERS MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 67: GLOBAL HOME CARE SETTINGS MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 68: GLOBAL HOME CARE SETTINGS MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 69: GLOBAL OTHER END-USERS MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 70: GLOBAL OTHER END-USERS MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 71: GLOBAL EPILEPSY DEVICES MARKET, BY GEOGRAPHY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 72: GLOBAL EPILEPSY DEVICES MARKET, BY GEOGRAPHY, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 73: NORTH AMERICA EPILEPSY DEVICES MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 74: NORTH AMERICA EPILEPSY DEVICES MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 75: LEADING PLAYERS OPERATING IN NORTH AMERICA EPILEPSY DEVICES MARKET
  • TABLE 76: EUROPE EPILEPSY DEVICES MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 77: EUROPE EPILEPSY DEVICES MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 78: LEADING PLAYERS OPERATING IN EUROPE EPILEPSY DEVICES MARKET
  • TABLE 79: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 80: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 81: LEADING PLAYERS OPERATING IN ASIA-PACIFIC EPILEPSY DEVICES MARKET
  • TABLE 82: REST OF WORLD EPILEPSY DEVICES MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 83: REST OF WORLD EPILEPSY DEVICES MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 84: LEADING PLAYERS OPERATING IN REST OF WORLD EPILEPSY DEVICES MARKET
  • TABLE 85: LIST OF ACQUISITIONS
  • TABLE 86: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
  • TABLE 87: LIST OF PARTNERSHIPS

LIST OF FIGURES

  • FIGURE 1: KEY MARKET TRENDS
  • FIGURE 2: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 3: OPPORTUNITY MATRIX
  • FIGURE 4: VENDOR LANDSCAPE
  • FIGURE 5: VALUE CHAIN ANALYSIS
  • FIGURE 6: KEY BUYING CRITERIA
  • FIGURE 7: GLOBAL EPILEPSY DEVICES MARKET, GROWTH POTENTIAL, BY PRODUCT TYPE, IN 2021
  • FIGURE 8: GLOBAL EPILEPSY DEVICES MARKET, BY CONVENTIONAL DEVICES, 2022-2030 (IN $ MILLION)
  • FIGURE 9: GLOBAL EPILEPSY DEVICES MARKET, BY WEARABLE DEVICES, 2022-2030 (IN $ MILLION)
  • FIGURE 10: GLOBAL EPILEPSY DEVICES MARKET, GROWTH POTENTIAL, BY WEARABLE DEVICES, IN 2021
  • FIGURE 11: GLOBAL EPILEPSY DEVICES MARKET, BY WATCHES, 2022-2030 (IN $ MILLION)
  • FIGURE 12: GLOBAL EPILEPSY DEVICES MARKET, BY BRACELETS, 2022-2030 (IN $ MILLION)
  • FIGURE 13: GLOBAL EPILEPSY DEVICES MARKET, BY CAMERA DEVICES, 2022-2030 (IN $ MILLION)
  • FIGURE 14: GLOBAL EPILEPSY DEVICES MARKET, BY MATTRESS DEVICES, 2022-2030 (IN $ MILLION)
  • FIGURE 15: GLOBAL EPILEPSY DEVICES MARKET, BY ANTI-SUFFOCATION PILLOWS, 2022-2030 (IN $ MILLION)
  • FIGURE 16: GLOBAL EPILEPSY DEVICES MARKET, BY OTHER WEARABLE DEVICES, 2022-2030 (IN $ MILLION)
  • FIGURE 17: GLOBAL EPILEPSY DEVICES MARKET, BY IMPLANTABLE DEVICES, 2022-2030 (IN $ MILLION)
  • FIGURE 18: GLOBAL EPILEPSY DEVICES MARKET, GROWTH POTENTIAL, BY TECHNOLOGY, IN 2021
  • FIGURE 19: GLOBAL EPILEPSY DEVICES MARKET, BY VAGUS NERVE STIMULATION, 2022-2030 (IN $ MILLION)
  • FIGURE 20: GLOBAL EPILEPSY DEVICES MARKET, BY DEEP BRAIN STIMULATION, 2022-2030 (IN $ MILLION)
  • FIGURE 21: GLOBAL EPILEPSY DEVICES MARKET, GROWTH POTENTIAL, BY DEEP BRAIN STIMULATION, IN 2021
  • FIGURE 22: GLOBAL EPILEPSY DEVICES MARKET, BY MOVEMENT DISORDERS, 2022-2030 (IN $ MILLION)
  • FIGURE 23: GLOBAL EPILEPSY DEVICES MARKET, BY EPILEPSY, 2022-2030 (IN $ MILLION)
  • FIGURE 24: GLOBAL EPILEPSY DEVICES MARKET, BY ACCELEROMETRY, 2022-2030 (IN $ MILLION)
  • FIGURE 25: GLOBAL EPILEPSY DEVICES MARKET, BY RESPONSIVE NEUROSTIMULATION, 2022-2030 (IN $ MILLION)
  • FIGURE 26: GLOBAL EPILEPSY DEVICES MARKET, GROWTH POTENTIAL, BY DETECTION & PREDICTION DEVICES TYPE, IN 2021
  • FIGURE 27: GLOBAL EPILEPSY DEVICES MARKET, BY ELECTROENCEPHALOGRAM, 2022-2030 (IN $ MILLION)
  • FIGURE 28: GLOBAL EPILEPSY DEVICES MARKET, BY INTRACRANIAL EEG, 2022-2030 (IN $ MILLION)
  • FIGURE 29: GLOBAL EPILEPSY DEVICES MARKET, BY SURFACE ELECTROMYOGRAPHY, 2022-2030 (IN $ MILLION)
  • FIGURE 30: GLOBAL EPILEPSY DEVICES MARKET, BY ELECTROCARDIOGRAPHY, 2022-2030 (IN $ MILLION)
  • FIGURE 31: GLOBAL EPILEPSY DEVICES MARKET, BY VIDEO DETECTION SYSTEMS, 2022-2030 (IN $ MILLION)
  • FIGURE 32: GLOBAL EPILEPSY DEVICES MARKET, BY ELECTRODERMAL ACTIVITY, 2022-2030 (IN $ MILLION)
  • FIGURE 33: GLOBAL EPILEPSY DEVICES MARKET, BY IMPLANTED ADVISORY SYSTEMS, 2022-2030 (IN $ MILLION)
  • FIGURE 34: GLOBAL EPILEPSY DEVICES MARKET, BY OTHER DETECTION & PREDICTION DEVICE TYPES, 2022-2030 (IN $ MILLION)
  • FIGURE 35: GLOBAL EPILEPSY DEVICES MARKET, GROWTH POTENTIAL, BY END-USER, IN 2021
  • FIGURE 36: GLOBAL EPILEPSY DEVICES MARKET, BY HOSPITALS & CLINICS, 2022-2030 (IN $ MILLION)
  • FIGURE 37: GLOBAL EPILEPSY DEVICES MARKET, BY NEUROLOGY CENTERS, 2022-2030 (IN $ MILLION)
  • FIGURE 38: GLOBAL EPILEPSY DEVICES MARKET, BY HOME CARE SETTINGS, 2022-2030 (IN $ MILLION)
  • FIGURE 39: GLOBAL EPILEPSY DEVICES MARKET, BY OTHER END-USERS, 2022-2030 (IN $ MILLION)
  • FIGURE 40: NORTH AMERICA EPILEPSY DEVICES MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN %)
  • FIGURE 41: UNITED STATES EPILEPSY DEVICES MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 42: CANADA EPILEPSY DEVICES MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 43: EUROPE EPILEPSY DEVICES MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN %)
  • FIGURE 44: UNITED KINGDOM EPILEPSY DEVICES MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 45: GERMANY EPILEPSY DEVICES MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 46: FRANCE EPILEPSY DEVICES MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 47: ITALY EPILEPSY DEVICES MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 48: SPAIN EPILEPSY DEVICES MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 49: NORDIC COUNTRIES EPILEPSY DEVICES MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 50: REST OF EUROPE EPILEPSY DEVICES MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 51: ASIA-PACIFIC EPILEPSY DEVICES MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN%)
  • FIGURE 52: CHINA EPILEPSY DEVICES MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 53: JAPAN EPILEPSY DEVICES MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 54: INDIA EPILEPSY DEVICES MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 55: SOUTH KOREA EPILEPSY DEVICES MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 56: INDONESIA EPILEPSY DEVICES MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 57: SINGAPORE EPILEPSY DEVICES MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 58: TAIWAN EPILEPSY DEVICES MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 59: AUSTRALIA & NEW ZEALAND EPILEPSY DEVICES MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 60: REST OF ASIA-PACIFIC EPILEPSY DEVICES MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 61: REST OF WORLD EPILEPSY DEVICES MARKET, REGIONAL OUTLOOK, 2021 & 2030 (IN %)
  • FIGURE 62: LATIN AMERICA EPILEPSY DEVICES MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 63: MIDDLE EAST & AFRICA EPILEPSY DEVICES MARKET, 2022-2030 (IN $ MILLION)